- Home
- ASPI vs STXS Comparison
ASPI vs STXS Comparison
Compare ASPI & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPI
- STXS
- Stock Information
- Founded
- ASPI 2021
- STXS 1990
- Country
- ASPI United States
- STXS United States
- Employees
- ASPI N/A
- STXS N/A
- Industry
- ASPI Major Chemicals
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ASPI Industrials
- STXS Health Care
- Exchange
- ASPI Nasdaq
- STXS Nasdaq
- Market Cap
- ASPI 158.4M
- STXS 173.5M
- IPO Year
- ASPI 2022
- STXS 2004
- Fundamental
- Price
- ASPI $7.71
- STXS $2.10
- Analyst Decision
- ASPI Strong Buy
- STXS Strong Buy
- Analyst Count
- ASPI 2
- STXS 2
- Target Price
- ASPI $4.50
- STXS $4.50
- AVG Volume (30 Days)
- ASPI 8.3M
- STXS 332.6K
- Earning Date
- ASPI 12-03-2024
- STXS 11-11-2024
- Dividend Yield
- ASPI N/A
- STXS N/A
- EPS Growth
- ASPI N/A
- STXS N/A
- EPS
- ASPI N/A
- STXS N/A
- Revenue
- ASPI $3,383,374.00
- STXS $25,143,000.00
- Revenue This Year
- ASPI $1,760.86
- STXS $1.16
- Revenue Next Year
- ASPI $314.74
- STXS $55.65
- P/E Ratio
- ASPI N/A
- STXS N/A
- Revenue Growth
- ASPI N/A
- STXS N/A
- 52 Week Low
- ASPI $1.65
- STXS $1.51
- 52 Week High
- ASPI $9.33
- STXS $3.29
- Technical
- Relative Strength Index (RSI)
- ASPI 59.78
- STXS 53.19
- Support Level
- ASPI $6.75
- STXS $1.96
- Resistance Level
- ASPI $8.15
- STXS $2.12
- Average True Range (ATR)
- ASPI 1.07
- STXS 0.12
- MACD
- ASPI -0.18
- STXS 0.01
- Stochastic Oscillator
- ASPI 44.71
- STXS 50.00
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.